Functional imaging biomarker guidance of VEGF treatment might be crucial due to the fact that anti-VEGF therapy might not primarily lead to shrinkage of the tumor, which could be assessed by morphological imaging, but to a devascularization of the tumor assessable only by functional imaging. This evidence concerns the gene VEGFA and neoplasm.